SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: DewDiligence_on_SI who wrote (345)1/18/2006 8:52:01 AM
From: sammaster  Read Replies (1) | Respond to of 447
 
smith barney gives no respect to macugen
they dont even mention that drug as a competitor :)
but they talk a lot about avastin off label...not sure which doctors would be willing to place a chemo agent in the eye that is not approved besides the ones in teaching/research centers...